Skip to search.
 FTSE 100 Up 0.90%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
2.71 Up 0.06(2.26%) 28 Aug 21:00
Add to Portfolio
Prev Close:2.65
Open:2.64
Bid:2.53 x 100
Ask:2.83 x 100
1y Target Est:7.38
Beta:-0.66001
Earnings Date:2 Nov - 6 Nov (Est.)
Day's Range:2.57 - 2.75
52wk Range:2.55 - 6.28
Volume:3,696,597
Avg Vol (3m):2,740,100
Market Cap:656.48m
P/E (ttm):N/A
EPS (ttm):-0.41
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ARNA at this time.

Comparison

Symbol% ChgMkt Cap
ARNAUp 2.26%656.48m
OREXUp 4.71%362.39m
GSKUp 0.10%99.70b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.50
Quarterly EPS Est (Sep-15) :-0.14
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.26

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback